{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T16:26:00Z","timestamp":1764433560812,"version":"3.37.3"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:00:00Z","timestamp":1716422400000},"content-version":"vor","delay-in-days":143,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019779","name":"Qatar National Library","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019779","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IDCases"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.idcr.2024.e01997","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T16:41:35Z","timestamp":1716568895000},"page":"e01997","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Metronidazole associated optic neuritis-induced irreversible vision loss: A case report and literature review"],"prefix":"10.1016","volume":"36","author":[{"given":"Haidar","family":"Barjas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Elshafei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shamin","family":"Mahmud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdel-Nasser","family":"Elzouki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.idcr.2024.e01997_bib1","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1086\/647939","article-title":"Metronidazole is still the drug of choice for treatment of anaerobic infections","volume":"50","author":"L\u00f6fmark","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idcr.2024.e01997_bib2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.7326\/0003-4819-93-1-59","article-title":"Central nervous system toxicity associated with metronidazole therapy","volume":"93","author":"Kusumi","year":"1980","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.idcr.2024.e01997_bib3","unstructured":"Viharika A., Basheer S., Bharathi G.V., Reddy T.R., Ramana V. Metronidazole Induced Meningtis: A Case Report DOI:10.9790\/0853\u20131811073739."},{"issue":"6","key":"10.1016\/j.idcr.2024.e01997_bib4","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1442-9071.2007.01537.x","article-title":"Reversible optic neuropathy due to metronidazole","volume":"35","author":"McGrath","year":"2007","journal-title":"Clin Exp Ophthalmol"},{"issue":"2","key":"10.1016\/j.idcr.2024.e01997_bib5","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1159\/000512625","article-title":"Metronidazole-Induced Irreversible Optic Neuropathy","volume":"12","author":"Peng","year":"2021","journal-title":"Case Rep Ophthalmol"},{"issue":"12","key":"10.1016\/j.idcr.2024.e01997_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-237141","article-title":"Reversible optic neuropathy secondary to metronidazole","volume":"13","author":"Anwyll","year":"2020","journal-title":"BMJ Case Rep"},{"issue":"5","key":"10.1016\/j.idcr.2024.e01997_bib7","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/clinids\/19.5.974","article-title":"Metronidazole-associated aseptic meningitis","volume":"19","author":"Corson","year":"1994","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idcr.2024.e01997_bib8","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1017\/cjn.2022.21","article-title":"Neuroimaging Evidence of Optic Tract Involvement in Metronidazole-Induced Optic Neuropathy","volume":"50","author":"Nuro","year":"2023","journal-title":"Can J Neurol Sci"},{"issue":"2","key":"10.1016\/j.idcr.2024.e01997_bib9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.arcped.2015.11.003","article-title":"Effets secondaires neuro-ophtalmologiques du traitement par m\u00e9tronidazole chez l\u2032enfant: \u00e0 propos de deux cas [Neuro-ophthalmic adverse effects of metronidazole treatment in children: Two case studies]","volume":"23","author":"Bouraoui","year":"2016","journal-title":"Arch Pediatr"},{"issue":"5","key":"10.1016\/j.idcr.2024.e01997_bib10","doi-asserted-by":"crossref","first-page":"395","DOI":"10.7326\/0003-4819-146-5-200703060-00017","article-title":"Metronidazole-induced aseptic meningitis during Helicobacter pylori eradication therapy","volume":"146","author":"Khan","year":"2007","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.idcr.2024.e01997_bib11","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0002-9394(14)77290-3","article-title":"Metronidazole and optic neuritis","volume":"112","author":"Putnam","year":"1991","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.idcr.2024.e01997_bib12","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1097\/00004728-200211000-00016","article-title":"Reversible MR imaging and MR spectroscopy abnormalities in association with metronidazole therapy","volume":"26","author":"Cecil","year":"2002","journal-title":"J Comput Assist Tomogr"},{"issue":"2","key":"10.1016\/j.idcr.2024.e01997_bib13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000085506","article-title":"Reversible visual deficit and Corpus callosum lesions due to metronidazole toxicity","volume":"53","author":"De Bleecker","year":"2005","journal-title":"Eur Neurol"}],"container-title":["IDCases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250924000738?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250924000738?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T01:13:42Z","timestamp":1718500422000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214250924000738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":13,"alternative-id":["S2214250924000738"],"URL":"https:\/\/doi.org\/10.1016\/j.idcr.2024.e01997","relation":{},"ISSN":["2214-2509"],"issn-type":[{"type":"print","value":"2214-2509"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metronidazole associated optic neuritis-induced irreversible vision loss: A case report and literature review","name":"articletitle","label":"Article Title"},{"value":"IDCases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idcr.2024.e01997","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e01997"}}